IDSA's response and personal lawsuits
0 views
Skip to first unread message
Mort Zuckerman
Jul 26, 2008, 8:03:39 PM7/26/08
to scilyme2
To: zerh...@od.nih.gov, Spin...@yahoogroups.com,
kshe...@calea.org, fit...@gmail.com, patrick.f...@usdoj.gov,
model...@sbcglobal.net, jdr...@nejm.org, let...@courant.com,
Jgerb...@cdc.gov, len...@courant.com, michae...@po.state.ct.us,
con...@po.state.ct.us, executiv...@nytimes.com, managing-
edi...@nytimes.com, news...@nytimes.com, the-...@nytimes.com,
biz...@nytimes.com, for...@nytimes.com, me...@nytimes.com,
nati...@nytimes.com, dv...@cdc.gov, brigidc...@optonline.net,
tr...@hotmail.com, ubi...@courant.com, ma...@concentric.net,
camp...@courant.com, jhorn...@fff.org, thomas...@usdoj.gov,
thoma...@po.state.ct.us, kur...@washpost.com,
georg...@washpost.com, hor...@courant.com,
commissi...@po.state.ct.us, cohen...@aol.com,
FalN...@aol.com, brans...@comcast.net, vts...@comcast.net,
o...@po.state.ct.us, da...@davila-dilzer.com,
scott....@po.state.ct.us, govern...@po.state.ct.us,
attorney...@po.state.ct.us, randall...@usdoj.gov
Cc: fra...@ucia.gov, dr-ahma...@president.ir,
eugener...@washpost.com, hor...@courant.com,
bmi...@newstimes.com, tr...@hotmail.com, rast...@aol.com,
billc...@gmail.com, thomas...@usdoj.gov, amcg...@rms-law.com,
rjmu...@aol.com, paulcrai...@yahoo.com,
sidney_b...@yahoo.com, criminal...@usdoj.gov,
karla.d...@usdoj.gov, christophe...@usdoj.gov
Subject: [SpinLyme] IDSA's response and personal lawsuits
Date: Jul 26, 2008 2:42 PM
They have pending lawsuits against them (Gary Wormser) for not
reporting adverse
events to OspA vaccination. The adverse events are related to the
immune dysregulation
caused by both chronic Lyme (shedding of Pam3Cys Osps- very similar to
HIV antigens),
and LYMErix vaccination.
http://www.actionlyme.org/GARY_WORMSER_SUED.htm
and as seen on the homepage and elsewhere on the website:
http://www.actionlyme.org/index.htm
IDSA does not mention the pending lawsuits against Gary Wormser or
anyone else over
defining Lyme as "a bad knee only" (Kaiser-Permanente's involvement
in the ALDF.com founded at New York Medical College) in their response
below.
The best defense is a good offense, and that's what the second OspA
vaccine
was about:
http://www.actionlyme.org/WORMSER_INSISTS_LYME_A_KNEE_DISEASE.htm
It's all meant to stop a greater criminal investigation that involves
many people
at Yale:
Steere, Fikrig, Flavell, Fish, Shapiro, Schoen, formerly, Lenny Sigal,
and all of
their criminal associates at the University of Corrupticut. CDC backs
this cabal
because Alan Barbour and Allen Steere are CDC officers, and CDC is
also criminally
liable for withholding information about how they know the current
testing schema
for Lyme is bogus, as demonstrated in their European patents with
SmithKline:
http://www.actionlyme.org/CDCS_PARTICIPATION_IN_LYME_CRIMES.htm
It appears they intended to handle the epidemic with bullshit and
trashing the victims.
You can believe that for sure when you see the graphics of the HIV
vaccine and LYMErix
on my homepage and here:
http://www.actionlyme.org/PAM3CYS_LYME_HIV.htm
So, IDSA is definitely lying to the public in their response to
Blumenthal. They
have conflicts of interest dating back to 1994, at Dearborn. See the
invitation
the CDC sent out about the Dearborn conference here:
http://www.actionlyme.org/DICKSON_FDA_SUBMISSION_FULL.htm
What happened at Dearborn is FRAUD.
This information can be FOIA'd from the FDA. They were given 15
copies of this
30 page booklet by myself on Jan 31, 2001; it was the entire crime in
a nutshell.
KMDickson
http://www.idsociety.org/Content.aspx?id=11182
IDSA Logo
NEWS RELEASE
For Release: Thursday, May 01, 2008
Contact Information
Contact Name: Steve Baragona
Contact E-mail: sbar...@idsociety.org
Contact Phone: (703) 299-0412
Contact Name: Monica Charleston
Contact E-mail: mchar...@pcipr.com
Contact Phone: (312) 558-1770
Agreement Ends Lyme Disease Investigation By Connecticut Attorney
General
Medical Validity of IDSA Guidelines Not Challenged
The Infectious Diseases Society of America (IDSA) has entered into an
agreement
with the Attorney General of Connecticut ending his investigation of
the Society’s
Lyme disease guidelines. Under the agreement, the guidelines remain in
effect; but
in an effort to clear the air, IDSA is voluntarily agreeing to an
extra step: a
one-time special review of the Lyme disease guidelines.
The agreement ends the investigation of IDSA and its volunteer
guideline panel members
without the filing of a complaint or the entry by a court of factual
or legal findings,
without IDSA paying any fines or penalties, and without imposing on
IDSA any restrictions
on its right to promulgate guidelines for Lyme disease or any other
disease or condition
in the manner it believes best serves public health.
“IDSA has agreed to this unique, singular review of our guidelines
because the panel
will consist solely of physicians and scientists,” said IDSA President
Donald Poretz,
MD. “We are confident that our guidelines for the diagnosis and
treatment of Lyme
disease represent the best advice that medicine currently has to
offer, as is the
case with all of the medical guidelines issued by the Society, and we
look forward
to the opportunity to put to rest any questions about them.”
The IDSA Lyme disease guidelines recommend against long-term
antibiotic therapy,
an unproven and potentially dangerous treatment. A small group of
physicians outside
the medical mainstream and their patients endorse such long-term
treatment, despite
the compelling medical evidence that it is ineffective and can have
serious, life-threatening
complications—and, furthermore, is extremely expensive. This agreement
does not
change the medical advice to patients: The 2006 Lyme disease
guidelines remain in
place.
Under the terms of the agreement announced today, IDSA will convene a
review panel
to conduct a comprehensive review of the Lyme-related literature to
determine whether
the 2006 guidelines should be revised or updated. While IDSA
periodically reviews
all of its treatment guidelines in order to keep them current, the
agreement allows
for an expanded process that includes an opportunity for public
presentation and
submission of information to ensure that all points of view are
presented to and
considered by the review panel.
IDSA is voluntarily agreeing to this extra scrutiny in the hope that
it will help
put to rest assertions that have been made – all of them unfounded –
that IDSA has
ignored divergent opinions in developing its Lyme disease guidelines.
This expanded
review process is pertinent to this unique case only. IDSA has not
agreed to use
it as a model for other IDSA guidelines, nor is IDSA urging other
medical organizations
and societies to use it.
The main actions of the agreement include:
*
Complete resolution of the Attorney General’s investigations,
issues, and
potential claims and causes of action against IDSA and its volunteer
panel members.
*
The current Lyme disease guidelines remain in effect. The
medical and scientific
basis of the 2006 guidelines remains in place and unchallenged.
*
IDSA will convene a review panel to determine whether the 2006
Lyme disease
guidelines should be revised or updated. Howard Brody, MD, PhD, who
has been jointly
selected by the Office of the Attorney General and IDSA, will serve as
an ombudsman
who will have a limited role that will focus on screening potential
conflicts of
interest. The ombudsman will not be involved in the operation of the
review panel.
Any proposed changes to the guidelines would require a supermajority
vote of 75
percent of the panel.
IDSA strongly disagrees with the Attorney General’s assertion that
panel members
had significant conflicts of interest. Panel members had no financial
interests
that would have affected, or been affected by, recommendations in the
guidelines.
The guidelines recommend generic drugs and generic diagnostic tests.
Panel members
do not stand to profit from any recommendation in the guidelines. In
fact, the panel
members denied themselves and their colleagues an opportunity to
generate a significant
amount of revenue when they recommended against expensive, repeated,
long-term antibiotic
therapy.
IDSA also strongly disagrees with the Attorney General’s allegation
that the Lyme
disease guideline panel excluded competing viewpoints. In fact, the
panel offered
an opportunity for other organizations and individuals to submit
additional evidence
and carefully considered all information provided. In 2000, a single
member of the
panel voluntarily stopped participating. He was not removed from the
panel, as the
Attorney General has alleged. Furthermore, all IDSA guidelines are
subjected to
a rigorous, multi-level review and approval process before they are
published, which
allows other clinicians who did not serve on the panel that developed
the guidelines
to ensure that the guidelines are relevant, accurate, useable, and
balanced.
IDSA’s guidelines—like all medical societies’ guidelines—are
voluntary. They are
for the benefit of physicians seeking the best possible advice from
experts in the
field. Medical societies do not have the authority or the desire to
dictate to physicians
how to practice medicine. Nor do they have the ability to dictate to
insurance companies
how to reimburse for services. No ties exist between IDSA and any
insurance company.
The physicians who wrote IDSA’s 2006 guidelines concluded that, for
nearly all patients,
a short course of antibiotics is an effective treatment for Lyme
disease. Studies
have proven that long-term antibiotic treatment, which is usually
given through
a needle and a catheter, is ineffective, expensive, and potentially
harmful. The
overuse of antibiotics also contributes to an important public health
threat: the
development of drug-resistant infections that are difficult if not
impossible to
treat.
“We recognize that medicine is always evolving, and we welcome the
opportunity that
the review panel provides to examine any new evidence and vet our
earlier findings,”
said Dr. Poretz. “We are pleased that under this agreement, the proper
diagnosis
and treatment for Lyme disease will be decided in a medical forum, not
a courtroom.
We hope this special review of the guidelines will help quell the
unfortunate controversy
surrounding the treatment of Lyme disease and ensure that patients
receive advice
and treatment based on the best available scientific and medical
evidence.”
###
IDSA is an organization of physicians, scientists, and other health
care professionals
dedicated to promoting health through excellence in infectious
diseases research,
education, prevention, and patient care. The Society, which has more
than 8,000
members, was founded in 1963 and is based in Arlington, VA. For more
information,
visit www.idsociety.org.
------------------------------------
Yahoo! Groups Links
kshe...@calea.org, fit...@gmail.com, patrick.f...@usdoj.gov,
model...@sbcglobal.net, jdr...@nejm.org, let...@courant.com,
Jgerb...@cdc.gov, len...@courant.com, michae...@po.state.ct.us,
con...@po.state.ct.us, executiv...@nytimes.com, managing-
edi...@nytimes.com, news...@nytimes.com, the-...@nytimes.com,
biz...@nytimes.com, for...@nytimes.com, me...@nytimes.com,
nati...@nytimes.com, dv...@cdc.gov, brigidc...@optonline.net,
tr...@hotmail.com, ubi...@courant.com, ma...@concentric.net,
camp...@courant.com, jhorn...@fff.org, thomas...@usdoj.gov,
thoma...@po.state.ct.us, kur...@washpost.com,
georg...@washpost.com, hor...@courant.com,
commissi...@po.state.ct.us, cohen...@aol.com,
FalN...@aol.com, brans...@comcast.net, vts...@comcast.net,
o...@po.state.ct.us, da...@davila-dilzer.com,
scott....@po.state.ct.us, govern...@po.state.ct.us,
attorney...@po.state.ct.us, randall...@usdoj.gov
Cc: fra...@ucia.gov, dr-ahma...@president.ir,
eugener...@washpost.com, hor...@courant.com,
bmi...@newstimes.com, tr...@hotmail.com, rast...@aol.com,
billc...@gmail.com, thomas...@usdoj.gov, amcg...@rms-law.com,
rjmu...@aol.com, paulcrai...@yahoo.com,
sidney_b...@yahoo.com, criminal...@usdoj.gov,
karla.d...@usdoj.gov, christophe...@usdoj.gov
Subject: [SpinLyme] IDSA's response and personal lawsuits
Date: Jul 26, 2008 2:42 PM
They have pending lawsuits against them (Gary Wormser) for not
reporting adverse
events to OspA vaccination. The adverse events are related to the
immune dysregulation
caused by both chronic Lyme (shedding of Pam3Cys Osps- very similar to
HIV antigens),
and LYMErix vaccination.
http://www.actionlyme.org/GARY_WORMSER_SUED.htm
and as seen on the homepage and elsewhere on the website:
http://www.actionlyme.org/index.htm
IDSA does not mention the pending lawsuits against Gary Wormser or
anyone else over
defining Lyme as "a bad knee only" (Kaiser-Permanente's involvement
in the ALDF.com founded at New York Medical College) in their response
below.
The best defense is a good offense, and that's what the second OspA
vaccine
was about:
http://www.actionlyme.org/WORMSER_INSISTS_LYME_A_KNEE_DISEASE.htm
It's all meant to stop a greater criminal investigation that involves
many people
at Yale:
Steere, Fikrig, Flavell, Fish, Shapiro, Schoen, formerly, Lenny Sigal,
and all of
their criminal associates at the University of Corrupticut. CDC backs
this cabal
because Alan Barbour and Allen Steere are CDC officers, and CDC is
also criminally
liable for withholding information about how they know the current
testing schema
for Lyme is bogus, as demonstrated in their European patents with
SmithKline:
http://www.actionlyme.org/CDCS_PARTICIPATION_IN_LYME_CRIMES.htm
It appears they intended to handle the epidemic with bullshit and
trashing the victims.
You can believe that for sure when you see the graphics of the HIV
vaccine and LYMErix
on my homepage and here:
http://www.actionlyme.org/PAM3CYS_LYME_HIV.htm
So, IDSA is definitely lying to the public in their response to
Blumenthal. They
have conflicts of interest dating back to 1994, at Dearborn. See the
invitation
the CDC sent out about the Dearborn conference here:
http://www.actionlyme.org/DICKSON_FDA_SUBMISSION_FULL.htm
What happened at Dearborn is FRAUD.
This information can be FOIA'd from the FDA. They were given 15
copies of this
30 page booklet by myself on Jan 31, 2001; it was the entire crime in
a nutshell.
KMDickson
http://www.idsociety.org/Content.aspx?id=11182
IDSA Logo
NEWS RELEASE
For Release: Thursday, May 01, 2008
Contact Information
Contact Name: Steve Baragona
Contact E-mail: sbar...@idsociety.org
Contact Phone: (703) 299-0412
Contact Name: Monica Charleston
Contact E-mail: mchar...@pcipr.com
Contact Phone: (312) 558-1770
Agreement Ends Lyme Disease Investigation By Connecticut Attorney
General
Medical Validity of IDSA Guidelines Not Challenged
The Infectious Diseases Society of America (IDSA) has entered into an
agreement
with the Attorney General of Connecticut ending his investigation of
the Society’s
Lyme disease guidelines. Under the agreement, the guidelines remain in
effect; but
in an effort to clear the air, IDSA is voluntarily agreeing to an
extra step: a
one-time special review of the Lyme disease guidelines.
The agreement ends the investigation of IDSA and its volunteer
guideline panel members
without the filing of a complaint or the entry by a court of factual
or legal findings,
without IDSA paying any fines or penalties, and without imposing on
IDSA any restrictions
on its right to promulgate guidelines for Lyme disease or any other
disease or condition
in the manner it believes best serves public health.
“IDSA has agreed to this unique, singular review of our guidelines
because the panel
will consist solely of physicians and scientists,” said IDSA President
Donald Poretz,
MD. “We are confident that our guidelines for the diagnosis and
treatment of Lyme
disease represent the best advice that medicine currently has to
offer, as is the
case with all of the medical guidelines issued by the Society, and we
look forward
to the opportunity to put to rest any questions about them.”
The IDSA Lyme disease guidelines recommend against long-term
antibiotic therapy,
an unproven and potentially dangerous treatment. A small group of
physicians outside
the medical mainstream and their patients endorse such long-term
treatment, despite
the compelling medical evidence that it is ineffective and can have
serious, life-threatening
complications—and, furthermore, is extremely expensive. This agreement
does not
change the medical advice to patients: The 2006 Lyme disease
guidelines remain in
place.
Under the terms of the agreement announced today, IDSA will convene a
review panel
to conduct a comprehensive review of the Lyme-related literature to
determine whether
the 2006 guidelines should be revised or updated. While IDSA
periodically reviews
all of its treatment guidelines in order to keep them current, the
agreement allows
for an expanded process that includes an opportunity for public
presentation and
submission of information to ensure that all points of view are
presented to and
considered by the review panel.
IDSA is voluntarily agreeing to this extra scrutiny in the hope that
it will help
put to rest assertions that have been made – all of them unfounded –
that IDSA has
ignored divergent opinions in developing its Lyme disease guidelines.
This expanded
review process is pertinent to this unique case only. IDSA has not
agreed to use
it as a model for other IDSA guidelines, nor is IDSA urging other
medical organizations
and societies to use it.
The main actions of the agreement include:
*
Complete resolution of the Attorney General’s investigations,
issues, and
potential claims and causes of action against IDSA and its volunteer
panel members.
*
The current Lyme disease guidelines remain in effect. The
medical and scientific
basis of the 2006 guidelines remains in place and unchallenged.
*
IDSA will convene a review panel to determine whether the 2006
Lyme disease
guidelines should be revised or updated. Howard Brody, MD, PhD, who
has been jointly
selected by the Office of the Attorney General and IDSA, will serve as
an ombudsman
who will have a limited role that will focus on screening potential
conflicts of
interest. The ombudsman will not be involved in the operation of the
review panel.
Any proposed changes to the guidelines would require a supermajority
vote of 75
percent of the panel.
IDSA strongly disagrees with the Attorney General’s assertion that
panel members
had significant conflicts of interest. Panel members had no financial
interests
that would have affected, or been affected by, recommendations in the
guidelines.
The guidelines recommend generic drugs and generic diagnostic tests.
Panel members
do not stand to profit from any recommendation in the guidelines. In
fact, the panel
members denied themselves and their colleagues an opportunity to
generate a significant
amount of revenue when they recommended against expensive, repeated,
long-term antibiotic
therapy.
IDSA also strongly disagrees with the Attorney General’s allegation
that the Lyme
disease guideline panel excluded competing viewpoints. In fact, the
panel offered
an opportunity for other organizations and individuals to submit
additional evidence
and carefully considered all information provided. In 2000, a single
member of the
panel voluntarily stopped participating. He was not removed from the
panel, as the
Attorney General has alleged. Furthermore, all IDSA guidelines are
subjected to
a rigorous, multi-level review and approval process before they are
published, which
allows other clinicians who did not serve on the panel that developed
the guidelines
to ensure that the guidelines are relevant, accurate, useable, and
balanced.
IDSA’s guidelines—like all medical societies’ guidelines—are
voluntary. They are
for the benefit of physicians seeking the best possible advice from
experts in the
field. Medical societies do not have the authority or the desire to
dictate to physicians
how to practice medicine. Nor do they have the ability to dictate to
insurance companies
how to reimburse for services. No ties exist between IDSA and any
insurance company.
The physicians who wrote IDSA’s 2006 guidelines concluded that, for
nearly all patients,
a short course of antibiotics is an effective treatment for Lyme
disease. Studies
have proven that long-term antibiotic treatment, which is usually
given through
a needle and a catheter, is ineffective, expensive, and potentially
harmful. The
overuse of antibiotics also contributes to an important public health
threat: the
development of drug-resistant infections that are difficult if not
impossible to
treat.
“We recognize that medicine is always evolving, and we welcome the
opportunity that
the review panel provides to examine any new evidence and vet our
earlier findings,”
said Dr. Poretz. “We are pleased that under this agreement, the proper
diagnosis
and treatment for Lyme disease will be decided in a medical forum, not
a courtroom.
We hope this special review of the guidelines will help quell the
unfortunate controversy
surrounding the treatment of Lyme disease and ensure that patients
receive advice
and treatment based on the best available scientific and medical
evidence.”
###
IDSA is an organization of physicians, scientists, and other health
care professionals
dedicated to promoting health through excellence in infectious
diseases research,
education, prevention, and patient care. The Society, which has more
than 8,000
members, was founded in 1963 and is based in Arlington, VA. For more
information,
visit www.idsociety.org.
------------------------------------
Yahoo! Groups Links
marieat...@gmail.com
Jul 29, 2008, 6:26:44 PM7/29/08
to scilyme2
Can idsa be sued for the positions they've taken? and the harm they've
done? and the suffering and deaths they've caused? And will
individual members be required to pay up?
On Jul 26, 8:03 pm, Mort Zuckerman <morph...@yahoo.com> wrote:
> To: zerho...@od.nih.gov, SpinL...@yahoogroups.com,
> kshep...@calea.org, fitz...@gmail.com, patrick.fitzger...@usdoj.gov,
> modelt1...@sbcglobal.net, jdra...@nejm.org, lett...@courant.com,
> Jgerberd...@cdc.gov, len...@courant.com, michael.c...@po.state.ct.us,
> conn...@po.state.ct.us, executive-edi...@nytimes.com, managing-
> edi...@nytimes.com, news-t...@nytimes.com, the-a...@nytimes.com,
> biz...@nytimes.com, fore...@nytimes.com, me...@nytimes.com,
> natio...@nytimes.com, dv...@cdc.gov, brigidcalla...@optonline.net,
> t...@hotmail.com, ubi...@courant.com, m...@concentric.net,
> campb...@courant.com, jhornber...@fff.org, thomas.car...@usdoj.gov,
> thomas.r...@po.state.ct.us, kur...@washpost.com,
> georgew...@washpost.com, hor...@courant.com,
> commissioner....@po.state.ct.us, cohencol...@aol.com,
> FalNie...@aol.com, bransfi...@comcast.net, vtsh...@comcast.net,
> o...@po.state.ct.us, d...@davila-dilzer.com,
> scott.mur...@po.state.ct.us, governor.r...@po.state.ct.us,
> attorney.gene...@po.state.ct.us, randall.samb...@usdoj.gov
> Cc: fran...@ucia.gov, dr-ahmadine...@president.ir,
> eugenerobin...@washpost.com, hor...@courant.com,
> bmil...@newstimes.com, t...@hotmail.com, rastr...@aol.com,
> billcurr...@gmail.com, thomas.car...@usdoj.gov, amcgui...@rms-law.com,
> rjmur...@aol.com, paulcraigrobe...@yahoo.com,
> sidney_blument...@yahoo.com, criminal.divis...@usdoj.gov,
> karla.dobin...@usdoj.gov, christopher.chris...@usdoj.gov
> Contact E-mail: sbarag...@idsociety.org
> Contact E-mail: mcharles...@pcipr.com
done? and the suffering and deaths they've caused? And will
individual members be required to pay up?
On Jul 26, 8:03 pm, Mort Zuckerman <morph...@yahoo.com> wrote:
> To: zerho...@od.nih.gov, SpinL...@yahoogroups.com,
> kshep...@calea.org, fitz...@gmail.com, patrick.fitzger...@usdoj.gov,
> modelt1...@sbcglobal.net, jdra...@nejm.org, lett...@courant.com,
> Jgerberd...@cdc.gov, len...@courant.com, michael.c...@po.state.ct.us,
> conn...@po.state.ct.us, executive-edi...@nytimes.com, managing-
> edi...@nytimes.com, news-t...@nytimes.com, the-a...@nytimes.com,
> biz...@nytimes.com, fore...@nytimes.com, me...@nytimes.com,
> natio...@nytimes.com, dv...@cdc.gov, brigidcalla...@optonline.net,
> t...@hotmail.com, ubi...@courant.com, m...@concentric.net,
> campb...@courant.com, jhornber...@fff.org, thomas.car...@usdoj.gov,
> thomas.r...@po.state.ct.us, kur...@washpost.com,
> georgew...@washpost.com, hor...@courant.com,
> commissioner....@po.state.ct.us, cohencol...@aol.com,
> FalNie...@aol.com, bransfi...@comcast.net, vtsh...@comcast.net,
> o...@po.state.ct.us, d...@davila-dilzer.com,
> scott.mur...@po.state.ct.us, governor.r...@po.state.ct.us,
> attorney.gene...@po.state.ct.us, randall.samb...@usdoj.gov
> Cc: fran...@ucia.gov, dr-ahmadine...@president.ir,
> eugenerobin...@washpost.com, hor...@courant.com,
> bmil...@newstimes.com, t...@hotmail.com, rastr...@aol.com,
> billcurr...@gmail.com, thomas.car...@usdoj.gov, amcgui...@rms-law.com,
> rjmur...@aol.com, paulcraigrobe...@yahoo.com,
> sidney_blument...@yahoo.com, criminal.divis...@usdoj.gov,
> karla.dobin...@usdoj.gov, christopher.chris...@usdoj.gov
>
> Subject: [SpinLyme] IDSA's response and personal lawsuits
>
> Date: Jul 26, 2008 2:42 PM
>
> They have pending lawsuits against them (Gary Wormser) for not
> reporting adverse
> events to OspA vaccination. The adverse events are related to the
> immune dysregulation
> caused by both chronic Lyme (shedding of Pam3Cys Osps- very similar to
> HIV antigens),
> and LYMErix vaccination.http://www.actionlyme.org/GARY_WORMSER_SUED.htm
> Subject: [SpinLyme] IDSA's response and personal lawsuits
>
> Date: Jul 26, 2008 2:42 PM
>
> They have pending lawsuits against them (Gary Wormser) for not
> reporting adverse
> events to OspA vaccination. The adverse events are related to the
> immune dysregulation
> caused by both chronic Lyme (shedding of Pam3Cys Osps- very similar to
> HIV antigens),
> Contact E-mail: mcharles...@pcipr.com
Reply all
Reply to author
Forward
0 new messages